To hear about similar clinical trials, please enter your email below

Trial Title: Tracer Targeting FAP PET Imaging in Patients

NCT ID: NCT05691894

Condition: Cancer

Study type: Interventional

Study phase: Early Phase 1

Overall status: Recruiting

Study design:

Allocation: Non-Randomized

Intervention model: Single Group Assignment

Primary purpose: Diagnostic

Masking: None (Open Label)

Intervention:

Intervention type: Drug
Intervention name: 18F-FAPI
Description: Patients will receive a tracer dose of 18F (8-10mCi) labelled FAPI
Arm group label: 18F-FAPI

Intervention type: Drug
Intervention name: 68Ga-FAPI
Description: Patients will receive a tracer dose of 68Ga (2-5mCi) labelled FAPI
Arm group label: 68Ga-FAPI

Summary: This is a single arm study to evaluate the safety and biodistribution of tracer targeting FAP PET Imaging in patients

Criteria for eligibility:
Criteria:
Inclusion Criteria: 1. Patients voluntarily signed informed consent; 2. Age 18-75, male or female; 3. Patients diagnosed with cancer confirmed by histopathology or cytology; 4. At least one measurable solid lesion has been examined according RECIST1.1 standard; 5. ECOG score 0~2. Exclusion Criteria: 1. Recovery from major trauma (including surgery) within 4 weeks prior to study treatment; 2. Patients with systemic or locally severe infections, or other serious coexisting diseases; 3. Patients with abnormal immune function or who have recently used immunosuppressive or potentiating agents including various vaccines; 4. Patients with autoimmune diseases, including rheumatoid arthritis; 5. Inadequate control of arrhythmias, including atrial fibrillation; 6. Uncontrolled hypertension; 7. Patients with allergies or allergies to any component of the imaging agent or antibody; 8. Patients who cannot undergo PET/CT imaging scan; 9. Syphilis, HBV, HCV, or HIV positive subjects; 10. Male and female subjects of reproductive age cannot take effective contraceptive measures; 11. Pregnant or lactating women; 12. Patients with a history of mental illness or related conditions; 13. Other subjects considered unsuitable by researchers.

Gender: All

Minimum age: 18 Years

Maximum age: 75 Years

Healthy volunteers: No

Locations:

Facility:
Name: Affiliated Hospital of Jiangnan University

Address:
City: Wuxi
Zip: 214000
Country: China

Status: Recruiting

Contact:
Last name: Chunjing Yu

Phone: 15312238622
Email: ycj_wxd1978@163.com

Start date: November 2, 2022

Completion date: November 2023

Lead sponsor:
Agency: Affiliated Hospital of Jiangnan University
Agency class: Other

Source: Affiliated Hospital of Jiangnan University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05691894

Login to your account

Did you forget your password?